Corrigendum to “Hyponatremia following esclicarbazepine therapy” [Seizure 29 (2015) 11–14]

The authors regret that there was a spelling mistake in points two and three of their highlights. This has now been corrected, as shown below: A high frequency of hyponatremia following ESL therapy was found (4/32). ESL related hyponatremia occurs in elderly stroke patients with comorbidities. ESL related hyponatremia is not dose related. Sodium levels need to be monitored in elderly on ESL therapy. In ESL related hyponatremia, it should be withdrawn or dose reduced. The authors would like to apologise for any inconvenience caused.